Show simple item record

dc.contributor.authorKumar A. U., Arun
dc.contributor.authorBrowne, Leonard D.
dc.contributor.authorLi, Xia
dc.contributor.authorAdeeb, Fahd
dc.contributor.authorPérez Ruiz, Fernando
dc.contributor.authorFraser, Alexander D.
dc.contributor.authorStack, Austin G.
dc.date.accessioned2018-12-20T11:55:03Z
dc.date.available2018-12-20T11:55:03Z
dc.date.issued2018-05-31
dc.identifier.citationPLOS ONE 13(5) : (2018) // Article ID e0198197es_ES
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10810/30469
dc.description.abstractBackground Elevated serum uric acid (sUA) concentrations are common in the general population and are associated with chronic metabolic conditions and adverse clinical outcomes. We evaluated secular trends in the burden of hyperuricaemia from 2006-2014 within the Irish health system. Methods Data from the National Kidney Disease Surveillance Programme was used to determine the prevalence of elevated sUA in adults, age > 18 years, within the Irish health system. Hyperuricaemia was defined as sUA > 416.4 mu mol/L in men and > 339.06 mu mol/L in women, and prevalence was calculated as the proportion of patients per year with mean sUA levels above sex-specific thresholds. Temporal trends in prevalence were compared from 2006 to 2014 while general estimating equations (GEE) explored variation across calendar years expressed as odds ratios (OR) and 95% Confidence intervals (CI). Results From 2006 to 2014, prevalence of hyperuricaemia increased from 19.7% to 25.0% in men and from 20.5% to 24.1% in women, P<0.001. The corresponding sUA concentrations increased significantly from 314.6 (93.9) in 2006 to 325.6 (96.2) in 2014, P<0.001. Age-specific prevalence increased in all groups from 2006 to 2014, and the magnitude of increase was similar for each age category. Adjusting for baseline demographic characteristics and illness indicators, the likelihood of hyperuricemia was greatest for patients in 2014; OR 1.45 (1.26-1.65) for men and OR 1.47 (1.29-1.67) in women vs 2006 (referent). Factors associated with hyperuricaemia included: worsening kidney function, elevated white cell count, raised serum phosphate and calcium levels, elevated total protein and higher haemoglobin concentrations, all P<0.001. Conclusions The burden of hyperuricaemia is substantial in the Irish health system and has increased in frequency over the past decade. Advancing age, poorer kidney function, measures of nutrition and inflammation, and regional variation all contribute to increasing prevalence, but these do not fully explain emerging trends.es_ES
dc.description.sponsorshipThis study is funded by the Health Research Board (HRA-2013-PHR-437 and HRA-2014-PHR-685), the Midwest Research and Education Foundation (MKid), and an unrestricted educational grant from the Menarini International Operations Luxemburg. Dr Stack and Dr. Fernando Perez-Ruiz have consulted for Menarini and Gruenenthal Pharma. Dr. Fernando Perez-Ruiz has delivered talks sponsored by Grunenthal and Menarini; delivered educational activities for Spanish Foundation for Rheumatology and a recipient of investigation grants from Cruces Rheumatology Association. The other authors have no relevant financial relationships to disclose.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library Sciencees_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectchronic kidney-diseasees_ES
dc.subjectserum uric-acides_ES
dc.subjectrenal-diseasees_ES
dc.subjectgoutes_ES
dc.subjectriskes_ES
dc.subjectprevalencees_ES
dc.subjectmetaanalysises_ES
dc.subjectpopulationes_ES
dc.subjectmanagementes_ES
dc.subjectnutritiones_ES
dc.titleTemporal trends in hyperuricaemia in the Irish health system from 2006-2014: A cohort studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder2018 Kumar A. U. et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0198197es_ES
dc.identifier.doi10.1371/journal.pone.0198197
dc.departamentoesMedicinaes_ES
dc.departamentoeuMedikuntzaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

2018 Kumar A. U. et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Except where otherwise noted, this item's license is described as 2018 Kumar A. U. et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.